Large-cap Industrials company Albemarle has logged a -0.3% change today on a trading volume of 406,703. The average volume for the stock is 1,753,638.
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Based in Charlotte, United States the company has 7,400 full time employees and a market cap of $21,050,877,952. Albemarle currently offers its equity investors a dividend that yields 0.9% per year.
The company is now trading -32.65% away from its average analyst target price of $266.37 per share. The 23 analysts following the stock have set target prices ranging from $155.0 to $344.0, and on average give Albemarle a rating of buy.
Over the last 12 months ALB shares have declined by -37.0%, which represents a difference of -56.0% when compared to the S&P 500. The stock's 52 week high is $334.55 per share and its 52 week low is $171.82. Based on Albemarle's average net margin growth of 62.4% over the last 6 years, its core business remains strong and the stock price may recover in the long term.
Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
---|---|---|---|---|
2023-02-15 | 7,320,104 | 2,689,816 | 37 | 825.0 |
2022-02-22 | 3,327,957 | 123,672 | 4 | -66.67 |
2021-02-19 | 3,128,909 | 375,764 | 12 | -20.0 |
2020-04-15 | 3,589,427 | 533,228 | 15 | -28.57 |
2019-02-27 | 3,374,950 | 693,562 | 21 | 950.0 |
2018-02-28 | 3,071,976 | 54,850 | 2 |